RU96102608A - PHARMACEUTICAL PRODUCT FOR IMMUNOMODULATION AND ADJUVANT (FROM ENGLISH ADJUVANT) TREATMENT - Google Patents
PHARMACEUTICAL PRODUCT FOR IMMUNOMODULATION AND ADJUVANT (FROM ENGLISH ADJUVANT) TREATMENTInfo
- Publication number
- RU96102608A RU96102608A RU96102608/14A RU96102608A RU96102608A RU 96102608 A RU96102608 A RU 96102608A RU 96102608/14 A RU96102608/14 A RU 96102608/14A RU 96102608 A RU96102608 A RU 96102608A RU 96102608 A RU96102608 A RU 96102608A
- Authority
- RU
- Russia
- Prior art keywords
- adjuvant
- treatment
- immunomodulation
- english
- pharmaceutical product
- Prior art date
Links
- 230000000240 adjuvant Effects 0.000 title claims 4
- 239000002671 adjuvant Substances 0.000 title claims 4
- 230000002519 immonomodulatory Effects 0.000 title claims 3
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 239000008177 pharmaceutical agent Substances 0.000 claims 4
- ASJSAQIRZKANQN-CRCLSJGQSA-N Deoxyribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 claims 2
- PYMYPHUHKUWMLA-LMVFSUKVSA-N aldehydo-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 claims 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N nicotinic acid Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims 2
- CIWBSHSKHKDKBQ-DUZGATOHSA-N (+)-Ascorbic acid Natural products OC[C@@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-DUZGATOHSA-N 0.000 claims 1
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N DL-alanine Chemical compound CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 claims 1
- 229960002743 Glutamine Drugs 0.000 claims 1
- 239000002211 L-ascorbic acid Substances 0.000 claims 1
- 235000000069 L-ascorbic acid Nutrition 0.000 claims 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Vitamin C Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims 1
- 229960005070 ascorbic acid Drugs 0.000 claims 1
- 238000001990 intravenous administration Methods 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 235000001968 nicotinic acid Nutrition 0.000 claims 1
- 229960003512 nicotinic acid Drugs 0.000 claims 1
- 239000011664 nicotinic acid Substances 0.000 claims 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- MYVIATVLJGTBFV-UHFFFAOYSA-M thiamine(1+) chloride Chemical compound [Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N MYVIATVLJGTBFV-UHFFFAOYSA-M 0.000 claims 1
Claims (4)
Д-рибозу - 10 - 35
2-Деокси-Д-рибозу - 10 - 35
ДЛ-альфа-аланин - 2 - 12
Никотиновую кислоту - 2 - 10
Л-аскорбиновую кислоту - 7 - 20
Тиаминхлорид - 0,2 - 2
Амид глутаминовой кислоты - 0,01 - 15
разведенные в 1000 г физиологического раствора.1. A pharmaceutical agent for immunomodulatory and adjuvant treatment, characterized in that it contains, g:
D-ribose - 10 - 35
2-Deoxy-D-ribose - 10 - 35
DL-alpha-alanine - 2 - 12
Nicotinic acid - 2 - 10
L-ascorbic acid - 7 - 20
Thiamine chloride - 0.2 - 2
Glutamic acid amide - 0.01 - 15
diluted in 1000 g of saline.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CZPV1385-93 | 1993-07-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
RU96102608A true RU96102608A (en) | 1998-05-20 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU93056633A (en) | ANTIALLERGIC COMPOSITION FOR TREATMENT OF EYES OR NOSE | |
ZA856841B (en) | Ibuprofen-containing soft gelatin capsules and process for preparing same | |
RU94027569A (en) | ORGANIC SALTS N, N'-DIACETHILTSISTINA, METHOD OF PRODUCTION, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT | |
FR2602423B1 (en) | PROCESS FOR THE PREPARATION OF A FENOFIBRATE-BASED MEDICINAL PRODUCT, OBTAINED BY THIS PROCESS | |
HK1003978A1 (en) | Composition for the treatment of schizophrenia | |
IT9021091A0 (en) | PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS HAVING INCREASED DISSOLUTION SPEED OF THE ACTIVE SUBSTANCE AND COMPOSITIONS OBTAINED | |
EP0472501A3 (en) | Codeinsalt of a substituted carbonacid, process of its preparation, its use and pharmaceutical preparations | |
MX9201736A (en) | AMINO ACID DERIVATIVES AND PROCEDURE FOR ITS PREPARATION. | |
DE3764111D1 (en) | COMBINATION OF MEDICINAL PRODUCTS. | |
RU96102608A (en) | PHARMACEUTICAL PRODUCT FOR IMMUNOMODULATION AND ADJUVANT (FROM ENGLISH ADJUVANT) TREATMENT | |
NO175745C (en) | Analogous Process for Preparation of Dibenzo (1,5) -Dioxocin-5-One | |
CA2038025A1 (en) | Optically active alkylenedioxybenzene derivatives and their use in therapy | |
FR2659553B1 (en) | PROCESS FOR THE PREPARATION OF HOMEOPATHIC COMPOSITIONS FROM AN INITIAL SOLUTION CONTAINING AN ACTIVE SUBSTANCE. | |
CA2065889A1 (en) | Increasing the choroidal blood flow | |
RU94046312A (en) | Use of biologically active ureido-derivatives for treatment lentivirus-induced disease, products containing ureido-derivatives | |
FI853868L (en) | PYRIDINDERIVAT, FOERFARANDE FOER FRAMSTAELLNING AV DESSA OCH PHARMACEUTICAL FOERENINGAR INNEHAOLLANDE DESSA. | |
HU904054D0 (en) | Medical preparations with stomach protecting effect containing n-benzyl-n-/(1s, 5s)-6,6-dimethyl-bicyclo/3.1.1/hept-2-yl-etoxy-ethyl/-morpholinium salts | |
AU586557B2 (en) | 1,4-dihydropyridine derivatives, process for their preparation and medicaments containing these compounds | |
RU96104214A (en) | METHOD FOR TREATING TRANSSUDATIVE FORMS OF CENTRAL CHORIORETHINAL DYSTROPHIES | |
RU97111692A (en) | Ointment with human interferon leukocyte "INTERON" | |
HU9200363D0 (en) | Process for the production of novel salts of 2-(2,6-dichloranilyno)-phenyl-acetic acid and medical preparations containing such active agents | |
IE873463L (en) | Compositions | |
IT1226147B (en) | PROCESS FOR THE PREPARATION OF PERFLUORO (2 BROMOETHYLVINYLETE). | |
TH5935EX (en) | Basket | |
ZA808014B (en) | N-(3-(1'-3"-oxapentamethyleneamino-ethylideneamino)-2,4,6-triiodobenzoyl)- -amino -methylpropionitrile |